Oncogenic activation of the PI3K–AKT pathway in cancer cells reprogrammes cellular metabolism by augmenting the activity of nutrient transporters and metabolic enzymes, thereby supporting the anabolic demands of aberrantly growing cells. This evidence concerns the gene AKT1 and cancer.